The DOI matches its Crossref record; 196 of the 197 references it cites were found in a registry or an index.
The pivotal role of dysregulated autophagy in the progression of non-alcoholic fatty liver disease
Open accessAbstract
Non-alcoholic fatty liver disease (NAFLD) is a clinicopathologic syndrome characterized by excessive fat deposition in hepatocytes and a major cause of end-stage liver disease. Autophagy is a metabolic pathway responsible for degrading cytoplasmic products and damaged organelles, playing a pivotal role in maintaining the homeostasis and functionality of hepatocytes. Recent studies have shown that pharmacological intervention to activate or restore autophagy provides benefits for liver function recovery by promoting the clearance of lipid droplets (LDs) in hepatocytes, decreasing the production of pro-inflammatory factors, and inhibiting activated hepatic stellate cells (HSCs), thus improving liver fibrosis and slowing down the progression of NAFLD. This article summarizes the physiological process of autophagy, elucidates the close relationship between NAFLD and autophagy, and discusses the effects of drugs on autophagy and signaling pathways from the perspectives of hepatocytes, kupffer cells (KCs), and HSCs to provide assistance in the clinical management of NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, several antifibrotic interventions -including traditional Chinese medicinal (TCM) compounds and pharmaceutical agents such as metformin, glucagon-like peptide-1 receptor agonists (GLP-1RAs) or SGLT2 inhibitors (SGLT2is)- promote restorative macrophage polarization, at least in part, through activation of AMPK-dependent pathways and enhance hepatic autophagy (34, 39, 41–44).”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Its induction promotes a shift toward a restorative macrophage phenotype, whereas proinflammatory stimuli such as LPS suppress autophagic flux and favor pro-fibrotic polarization (34, 38–40).”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [39]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,306
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418 · cited 1×
“Finally, autophagosomes form autolysosomes by transporting their cargo into lysosomes and fusing with them (44).”
BackgroundAutophagy regulates lipid metabolism
Singh, R., Kaushik, S., Wang, Y., Xiang, Y., Novak, I., Komatsu, M., Tanaka, K., Cuervo, A. M., & Czaja, M. J. (2009) · Nature · doi:10.1038/nature07976 · Cited by 3,975 · cited 1×
“Hepatocyte autophagy can enhance lipophagy, selectively degrade LDs, and thus improve lipid metabolism in NAFLD (96, 97).”
BackgroundMAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
Eslam, M., Sanyal, A. J., George, J., Sanyal, A., Neuschwander-Tetri, B., Tiribelli, C., Kleiner, D. E., Brunt, E., Bugianesi, E., Yki-Järvinen, H., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.312 · Cited by 3,286 · cited 1×
“NAFLD is a metabolic disease involving abnormal liver fat metabolism, which has recently been renamed as metabolism-associated fatty liver disease (MAFLD) (3), as represented by NAFLD in the following article.”
BackgroundMechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909 · cited 1×
“However, activation of HSCs enhances extracellular matrix (ECM) production, which is a key initiating event in hepatic fi brosis and plays a crucial role in NAFLD progression (109, 110).”
BackgroundHepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842 · cited 1×
“HSCs, situated in the Disse space between the lateral basal region of hepatocytes and the surface of sinusoidal endothelial cells, serve as the principal producers of collagen within the liver (107).”
BackgroundBiological Functions of Autophagy Genes: A Disease Perspective
Levine, B., & Kroemer, G. (2019) · Cell · doi:10.1016/j.cell.2018.09.048 · Cited by 2,832 · cited 1×
“These ATG proteins, in conjunction with autophagy regulatory factors, play a crucial role in regulating the autophagic process (26, 27).”
BackgroundMechanism and medical implications of mammalian autophagy
Dikic, I., & Elazar, Z. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0003-4 · Cited by 2,771 · cited 3×
“Signi fi cantly, autophagosomes and autolysosomes are two essential components in the formation of autophagy (17).”
BackgroundAn Overview of Autophagy: Morphology, Mechanism, and Regulation
Parzych, K. R., & Klionsky, D. J. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5371 · Cited by 2,521 · cited 4×
“Three types of autophagy have been identi fi ed, namely microautophagy, macroautophagy, and CMA.”
BackgroundInfluentialFrom endoplasmic-reticulum stress to the inflammatory response
Zhang, K., & Kaufman, R. J. (2008) · Nature · doi:10.1038/nature07203 · Cited by 2,010
Cited by
Giangregorio, F., Mosconi, E., Debellis, M. G., Provini, S., Esposito, C., Garolfi, M., Oraka, S., KALOUDI, O., Mustafazade, G., Marín‐Baselga, R., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13195880 · Cited by 78
“Fibrosis in MASLD can be categorized into stages F0 to F4, with F3 and F4 being considered advanced fibrosis [62].”
BackgroundEldken, Z. H., Youssef, O. M., Khalil, R. M., Kassab, A., Ramadan, A., & Sakr, N. H. (2025) · Scientific Reports · doi:10.1038/s41598-025-11135-2 · Cited by 7
“Although TNF-α is not pyroptosis-specific, its elevated expression and histological evidence indicate pyroptosis in MAFLD.”
InfluentialXie, W., Lv, Y., Zhou, Z., Wang, G., Zhang, X., Peng, D., Yang, H., Liao, J., Sun, X., Lin, W., et al. (2026) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-026-01177-9 · Cited by 6
“In the context of NAFLD, autophagy plays a critical role in regulating lipid metabolism and modulating inflammatory responses (Shen et al. 2024).”
InfluentialAutophagy as a therapeutic linchpin in metabolic diseases and obesity-associated diabetes
Vakili, O., Klionsky, D. J., Reiter, R. J., Ren, J., Deshpande, A., Ahn, K. S., Cho, W., Hushmandi, K., & Kumar, A. P. (2026) · Autophagy · doi:10.1080/15548627.2026.2636096 · Cited by 10
“…primarily of misfolded and crosslinked KRT8 (keratin 8) and KRT18, ubiquitinated proteins such as SQSTM1/p62, and other damaged proteins, which accumulate in damaged hepatocytes especially during alcoholic and nonalcoholic steatohe-patitis, as well as other liver metabolic defects [201–203].”
Pesticides Drive Liver Diseases Through Non-Apoptotic Regulated Cell Death Pathways
Khairullina, Z. S., Kurmangaliyeva, S. S., Yussupov, R., Kelimberdiyeva, E., Tryfonyuk, L., Shapambayev, N., Seidakhmetova, A., Medetbekov, T., & Tkachenko, A. (2026) · Diseases · doi:10.3390/diseases14030096 · Cited by 3
Metadata
- Authors
- Shen, Q., Yang, M., Wang, S., Chen, X., Chen, S., Zhang, R., Xiong, Z., & Leng, Y.
- Affiliations
- Changchun University of Chinese Medicine (CN)
- Corresponding author
- Leng, Yan
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2024-08-08
- Volume
- 15
- Pages
- 1374644-1374644
- ISSN
- 1664-2392 (ISSN-L)
- PMC
- PMC11338765
- OpenAlex
- W4401435151
- Cited by
- 15
- References
- 197
- Citations by year
- 2026: 9 · 2025: 5 · 2024: 1
- FWCI
- 0.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Endocrinology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Natural Science Foundation of Jilin Province
- People's Government of Jilin Province
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- non-alcoholic fatty liver disease, autophagy, hepatic stellate cells, liver fibrosis, hepatocytes, Kupffer cells, autophagy signaling, pro-inflammatory factors, NAFLD progression
- MeSH terms
- Animals, Autophagy, Humans, Kupffer Cells, Signal Transduction, Disease Progression, Hepatocytes, Hepatic Stellate Cells, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The pivotal role of dysregulated autophagy in the progression of non-alcoholic fatty liver disease. https://app.cochat.ai/papers/10.3389/fendo.2024.1374644
- The paper
- Shen, Q., Yang, M., Wang, S., Chen, X., Chen, S., Zhang, R., Xiong, Z., & Leng, Y. (2024). The pivotal role of dysregulated autophagy in the progression of non-alcoholic fatty liver disease. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2024.1374644
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.